Progyny Inc
Closed
SectorHealthcare
27.43 1.4
Overview
Share price change
24h
Min
26.79
Max
27.56
Income | 28M 52M |
|---|---|
Sales | 22M 351M |
P/E Sector Avg | 28.196 56.597 |
EPS | 0.34 |
Profit margin | 14.917 |
Employees | 835 |
EBITDA | 5.9M 44M |
Next Earnings | 5 lis 2026 |
|---|
Market Cap | -448M 2B |
|---|---|
Previous open | 26.03 |
Previous close | 27.43 |
News Sentiment
By Acuity
40%
60%
112 / 339 Ranking in Healthcare
Progyny Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Progyny Inc Forecast
Sentiment
By Acuity
112 / 339 Ranking in Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Progyny Inc
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.